Literature DB >> 6541200

Oral zinc as an adjunct to dapsone in lepromatous leprosy.

N K Mathur, R A Bumb, H N Mangal, M L Sharma.   

Abstract

Oral zinc was tried in 15 cases of multibacillary leprosy as an immunostimulant in addition to conventional antileprosy drugs. Results were compared with those in ten similar cases treated with dapsone alone. Cases treated with zinc showed faster clinical improvement, regrowth of eyebrows, rapid fall in the bacterial index (BI) and in the bacterial index in the granuloma (BIG), early and greater influx in lymphocytes in the granuloma, and neovascularization. Upgrading occurred in 6 out of 15 patients taking zinc, but in only 1 out of 10 patients in the control group. Five out of six patients who showed upgrading in the treated group became lepromin positive. Only one patient (BL) showed lepromin conversion in the control group.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6541200

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN: 0148-916X


  4 in total

1.  Inhibition of apoptosis by ionomycin and zinc in peripheral blood mononuclear cells (PBMC) of leprosy patients.

Authors:  A Gupta; V K Sharma; H Vohra; N K Ganguly
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

Review 2.  Zinc therapy in dermatology: a review.

Authors:  Mrinal Gupta; Vikram K Mahajan; Karaninder S Mehta; Pushpinder S Chauhan
Journal:  Dermatol Res Pract       Date:  2014-07-10

Review 3.  Zinc in Infection and Inflammation.

Authors:  Nour Zahi Gammoh; Lothar Rink
Journal:  Nutrients       Date:  2017-06-17       Impact factor: 5.717

4.  Increased oxidative stress in elderly leprosy patients is related to age but not to bacillary load.

Authors:  Pedro Henrique Lopes da Silva; Katherine Kelda Gomes de Castro; Mayara Abud Mendes; Thyago Leal Calvo; Júlia Monteiro Pereira Leal; Mariana de Andréa Vilas-Boas Hacker; José Augusto da Costa Nery; Euzenir Nunes Sarno; Roberto Alves Lourenço; Milton Ozório Moraes; Flávio Alves Lara; Danuza Esquenazi
Journal:  PLoS Negl Trop Dis       Date:  2021-03-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.